Evidence of bleeding diathesis or clinically significant coagulopathy
Known bleeding diathesis or coagulopathy
Evidence or history of bleeding diathesis or coagulopathy
Evidence or history of bleeding diathesis or coagulopathy
History of bleeding diathesis or coagulopathy
Evidence of bleeding diathesis or clinically significant coagulopathy.
Evidence or history of bleeding diathesis or coagulopathy
Evidence or history of bleeding diathesis or coagulopathy
Evidence or history of bleeding diathesis or coagulopathy
History of tumor-related or other serious hemorrhage, bleeding diathesis, or underlying coagulopathy
No coagulopathy or bleeding diathesis
Evidence of bleeding diathesis or coagulopathy
Evidence of bleeding diathesis or coagulopathy
Clinical evidence of bleeding diathesis or coagulopathy
Evidence of bleeding diathesis or coagulopathy
Patients who have clinical history of coagulopathy, bleeding diathesis or thrombosis within the past year
Evidence or history of bleeding diathesis or coagulopathy
Evidence or history of bleeding diathesis or coagulopathy
Inherited bleeding diathesis or coagulopathy with the risk of bleeding
REGORAFENIB EXCLUSION CRITERIA: Evidence or history of bleeding diathesis or coagulopathy
History of or genetic predisposition to a bleeding diathesis or coagulopathy
Evidence of bleeding diathesis or coagulopathy
Evidence of bleeding diathesis or coagulopathy
Patients who have clinical history of coagulopathy, bleeding diathesis or thrombosis within the past year
Evidence of clinically significant bleeding diathesis or underlying coagulopathy, non-healing wound
The subject has inherited bleeding diathesis or coagulopathy with the risk of bleeding
Evidence of bleeding diathesis, coagulopathy as documented by an elevated PT, PTT or bleeding time
Clinical evidence of bleeding diathesis or coagulopathy
History or evidence of inherited bleeding diathesis or coagulopathy with a risk of bleeding
Evidence or history of bleeding diathesis or coagulopathy
Evidence of bleeding diathesis or coagulopathy (including clinically significant hemoptysis)
Evidence of active bleeding diathesis or coagulopathy\r\n* For the NSCLC expanded cohort only: history of “blood tinged” sputum allowed
Bleeding or evidence or history of clinically significant bleeding diathesis or coagulopathy within the last 3 months
Clinically significant bleeding diathesis or coagulopathy
History or evidence of inherited bleeding diathesis or coagulopathy with a risk of bleeding
Evidence or history of bleeding diathesis or coagulopathy
Patients with a known coagulopathy or bleeding diathesis or require the use of systemic anticoagulant medication are not eligible
Evidence of bleeding diathesis or coagulopathy
Evidence or history of bleeding diathesis or coagulopathy
Evidence of bleeding diathesis or coagulopathy
Evidence or history of bleeding diathesis or coagulopathy
Patients must not have a known bleeding diathesis or coagulopathy
Evidence of bleeding diathesis or coagulopathy
Evidence or history of bleeding diathesis or coagulopathy
Evidence or history of bleeding diathesis or coagulopathy
No significant bleeding within the past 6 months; no bleeding diathesis or coagulopathy
Evidence of bleeding diathesis or coagulopathy.
Evidence of bleeding diathesis or coagulopathy
Patients are excluded if they have evidence of bleeding diathesis or coagulopathy
Evidence of bleeding diathesis or coagulopathy
Evidence or history of bleeding diathesis or coagulopathy
Evidence or history of bleeding diathesis or coagulopathy
History or evidence of inherited bleeding diathesis or coagulopathy with the risk of bleeding
Evidence or history of bleeding diathesis or coagulopathy.
Evidence or history of bleeding diathesis or coagulopathy
Evidence of bleeding diathesis or coagulopathy
Evidence of bleeding diathesis or coagulopathy within the past 6 months
Evidence of bleeding diathesis or coagulopathy within 3 months
Patients with a history of hemoptysis, bleeding diathesis, known platelet disorder, or coagulopathy are not eligible
Evidence of bleeding diathesis or clinically significant coagulopathy
Evidence of prior or current coagulopathy or bleeding diathesis
Clinically-significant evidence of bleeding diathesis or coagulopathy as so judged by the treating physician
Evidence or history of bleeding diathesis or coagulopathy
Patients must have no evidence of bleeding diathesis or coagulopathy; patients must have no pathologic condition other than mesothelioma that carries a high risk of bleeding
Evidence or history of bleeding diathesis or coagulopathy
Pre-existing bleeding diathesis, coagulopathy or hemorrhage
The subject has inherited bleeding diathesis or coagulopathy with the risk of bleeding
Patients must have no known bleeding diathesis or coagulopathy that would make intratumoral injection or biopsy unsafe.
Evidence or history of bleeding diathesis or coagulopathy
Evidence or history of bleeding diathesis or coagulopathy
Evidence or history of bleeding diathesis or coagulopathy
Evidence or history of bleeding diathesis or coagulopathy
Evidence of bleeding diathesis or clinically significant coagulopathy
Evidence of bleeding diathesis or a clinically significant coagulopathy
Patients with an active, bleeding diathesis or significant coagulopathy
History of bleeding diathesis or coagulopathy. (Patients on stable anticoagulant therapy are eligible.)
Evidence of bleeding diathesis or significant coagulopathy
Evidence or history of bleeding diathesis or uncontrolled coagulopathy
Evidence or history of a bleeding diathesis or coagulopathy, including therapy-induced coagulopathy
Evidence or history of bleeding diathesis or coagulopathy
Concurrent use of anti-coagulant drugs (not including prophylactic doses), history of coagulopathy, or evidence of bleeding diathesis or coagulopathy
Presence of bleeding diathesis or coagulopathy
No known bleeding diathesis or coagulopathy
History of bleeding diathesis or coagulopathy
Coagulopathy or bleeding diathesis
Evidence of bleeding diathesis or coagulopathy
Evidence or history of bleeding diathesis or coagulopathy
Evidence or history of bleeding diathesis or coagulopathy.
Evidence or history of bleeding diathesis or coagulopathy
Evidence or history of bleeding diathesis or coagulopathy
Evidence of clinically significant bleeding diathesis or coagulopathy
Active GI bleeding and any bleeding diathesis or coagulopathy that is not correctable by usual therapy or hemostatic agents
Evidence of clinically significant bleeding diathesis or underlying coagulopathy (e.g. INR > 1.5 without vitamin K antagonist therapy), non-healing wound
Patients must not have a bleeding diathesis, hereditary of acquired bleeding disorder or coagulopathy
History of bleeding diathesis or coagulopathy other than that due to anticoagulation therapy
Evidence or history of bleeding diathesis or coagulopathy
Evidence or history of bleeding diathesis or coagulopathy at the time of enrollment
History or evidence of inherited bleeding diathesis or coagulopathy with a risk of bleeding and active gastrointestinal bleeding
Evidence or history of bleeding diathesis or coagulopathy
History of tumor-related or other serious hemorrhage, bleeding diathesis, or underlying coagulopathy
Evidence or history of bleeding diathesis or coagulopathy
Any evidence of bleeding diathesis or coagulopathy
Evidence or history of bleeding diathesis or coagulopathy
Clinically significant bleeding diathesis or coagulopathy, including known platelet function disorders
Evidence or history of bleeding diathesis or coagulopathy
Known bleeding diathesis or coagulopathy
Evidence or history of bleeding diathesis or coagulopathy
Known bleeding diathesis or coagulopathy
Patient must not have a known bleeding diathesis or coagulopathy
